Laminar Pharmaceuticals SA

Where the EU money came from

Funding by EU programme. Amounts are Laminar Pharmaceuticals SA's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Laminar Pharmaceuticals SA led 2 of them as coordinator. Each links to the official record.

• PANC561Coordinator

  LAM561 BEATS PANCREATIC CANCER

  Horizon 2020 · 2021–2023 · Project on CORDIS ↗

  €161ktheir share
• CLINGLIOCoordinator

  A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €3.0Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• University of Newcastle Upon TyneUnited Kingdom · 1 shared project
• Institut Gustave RoussyFrance · 1 shared project
• Universita Degli Studi di SalernoItaly · 1 shared project
• Universitat de Les Illes BalearsSpain · 1 shared project
• Fondazione Irccs Istituto Neurologico Carlo BestaItaly · 1 shared project
• Biokeralty Research Institute AieSpain · 1 shared project
• The Royal Marsden National Health Service TrustUnited Kingdom · 1 shared project
• Specialized Medical Services-Oncology BVNetherlands · 1 shared project
• Research Fund of the Hadassah Medical Organization (R.a)Israel · 1 shared project
• Praxis Pharmaceutical SASpain · 1 shared project
• Lipodom Kutato Fejleszto Es Tanacsado Korlatolt Felelossegu TarsasagHungary · 1 shared project
• Lana Management and Business Research International LLCUnited States · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• drug discovery
• lipids
• neurobiology
• oncology
• pancreatic cancer
• pathology
• pharmaceutical drugs
• public health
• surgery